CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2023
Top Holdings1,059 positions
ACTIVISION BLIZZARD INC | 3.3M | $275.7M | 4.9% | — | — | — | Increased — |
HORIZON THERAPEUTICS PUB L | 1.2M | $120.2M | 2.1% | — | — | — | Increased — |
Palo Alto Networks Inc | 420,200 | $107.4M | 1.9% | — | — | — | Decreased — |
ACTIVISION BLIZZARD INC | 1.3M | $107M | 1.9% | — | — | — | Increased — |
OCCIDENTAL PETE CORP | 1.4M | $81.3M | 1.4% | — | — | — | Increased — |
HORIZON THERAPEUTICS PUB L | 645,700 | $66.4M | 1.2% | — | — | — | New — |
iShares Trust US HOME CONS ETF | 775,000 | $66.2M | 1.2% | — | — | — | Unchanged — |
EXACT SCIENCES CORP | 690,400 | $64.8M | 1.1% | — | — | — | Increased — |
Alphabet Inc. | 430,000 | $52M | 0.9% | — | — | — | Unchanged — |
American Tower Corporation | 259,600 | $50.3M | 0.9% | — | — | — | New — |
The Procter & Gamble Co. | 320,000 | $48.6M | 0.9% | — | — | — | New — |
BRISTOL-MYERS SQUIBB CO | 698,500 | $44.7M | 0.8% | — | — | — | Increased — |
WORLD WRESTLING ENTMT INC | 388,000 | $42.1M | 0.7% | — | — | — | Decreased — |
BRISTOL-MYERS SQUIBB CO | 648,500 | $41.5M | 0.7% | — | — | — | Increased — |
CHARTER COMMUNICATIONS INC N | 110,000 | $40.4M | 0.7% | — | — | — | Decreased — |
ARGENX SE | 100,000 | $39M | 0.7% | — | — | — | Increased — |
Meta Platforms Inc | 131,300 | $37.7M | 0.7% | — | — | — | Unchanged — |
FIRST SOLAR INC | 180,000 | $34.2M | 0.6% | — | — | — | Decreased — |
ROYAL CARIBBEAN GROUP | 325,000 | $33.7M | 0.6% | — | — | — | Increased — |
KARUNA THERAPEUTICS INC | 154,500 | $33.5M | 0.6% | — | — | — | Decreased — |
Caption Management, LLC manages $5.6B across 1059 positions as of Q2 2023. Top holdings: ATVI puts (4.9%), HZNP puts (2.1%), PANW puts (1.9%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 165 new positions, 152 exits, 70 increased. No standout high-conviction moves this quarter. Portfolio: $5.6B across 1059 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR